Vaginitis Therapeutics Market, By Disease (Anti-bacterial, Hormone and Anti-fungal), By Product, By Distribution Channel, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV5973
|
Published Date
September 2026
|
Pages
322
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Vaginitis Therapeutics market size was valued at US$ 4,051.3 Million in 2025, expanding at a CAGR of 8.1% from 2026 to 2033.
Vaginitis therapeutics involves the administration of medications, including antifungals, antibiotics, and hormones, for the treatment of vaginal infections. Such medications are very effective in alleviating symptoms like itching, discharge, and pain.
The types of the major therapeutic agents for vaginitis include nitroimidazole drugs, lincosamide antibiotics, triazoles, and imidazoles. Nitroimidazole drugs are antimicrobial drugs and are employed against parasitic, mycobacterial, and anaerobic Gram-positive and Gram-negative bacteria. The route of administration can be oral, topical, and vaginal for conditions such as bacterial vaginosis, trichomoniasis, vulvovaginal candidiasis, and many more. The end-users include hospitals, gynecology centers, surgery centers, and clinics.
Vaginitis Therapeutics Market- Market Dynamics
Increasing Prevalence of Sexually Transmitted Diseases (STDs) to Propel Market Demand
The rising number of sexually transmitted diseases (STDs), especially trichomoniasis, is one of the major drivers in the Vaginitis Therapeutics market due to the increasing need to treat such illnesses properly using antimicrobial drugs in order to relieve the symptoms, prevent complications, and handle the infection. For instance, in April 2025, according to a study published in Cureus and available through the National Centre for Biotechnology Information (NCBI), based on the results of more than 50,000 patients, the prevalence of sexually transmitted diseases (STDs) was recorded at 16.2%, and it can be expected that an increase in the prevalence rate of such diseases worldwide will lead to an increase in the demand for vaginitis treatments and remedies. This growing disease burden is expected to increase demand for effective vaginitis therapeutics and treatment options.
Vaginitis Therapeutics Market- Segmentation Analysis:
The Global Vaginitis Therapeutics market is segmented on the basis of Disease, Product, Distribution Channel, and Region.
Antibacterial therapies hold a significant share in the Vaginitis Therapeutics market since bacterial vaginosis, that is one of the common subtypes of vaginitis, always requires the use of antibacterial treatment, along with an increase in the awareness regarding different types of vaginitis and an increase in the incidence rate of recurrence of infection. For instance, in May 2026, according to the UK government, the number of antibiotic-resistant bloodstream infections in England increased by 13.1% from 18,103 cases to 20,484 cases. Also, the selected bacterial bloodstream infections increased from 173,513 cases to 183,990 cases, showing the increasing importance of bacteria and their infections and the growing requirement of effective antibacterials. These trends highlight the growing demand for effective antibacterial therapies to manage bacterial infections.
In terms of product type, prescription therapeutics hold a significant share in the Vaginitis Therapeutics market, as these drugs provide a specialised and medically controlled way of treating severe, chronic, and complex vaginal infections. For instance, in March 2026, according to the Press Information Bureau (PIB), the value of the domestic pharma market in India stood at USD 60,000 million and is expected to increase to USD 130,000 million in 2030, while India has approximately 60,000 generic brands in 60 therapeutic segments. The pharma sector in India ranks third in the world in terms of volume and eleventh in terms of value, and the Indian pharma sector consists of more than 3,000 companies with 10,500 manufacturing units. This growth strengthens the availability, accessibility, and adoption of prescription therapeutics across diverse treatment needs.
Vaginitis Therapeutics Market- Geographical Insights
North America holds a notable place in the Vaginitis Therapeutics market, driven by the prevalence of infections such as bacteria and fungi, developed healthcare infrastructure, and increased awareness of reproductive health. For instance, in May 2025, according to the U.S. Centres for Disease Control and Prevention (CDC), the number of fatalities, hospitalisations, and outpatient visits because of fungal diseases in the United States is estimated to be around 7,300 deaths, 130,000 hospitalisations, and 13 million outpatient visits annually from the fungal diseases in the United States. The CDC estimates that the economic burden of fungal infections in the United States is around $19 billion per annum, signifying the high prevalence of fungi-related infections. These trends underscore North America\'s demand for effective vaginitis therapeutics and advanced treatment options.
Vaginitis Therapeutics Market- Competitive Landscape:
The Vaginitis Therapeutics market is highly fragmented with intense competition among different global companies like Pfizer Inc., Merck & Co. Inc., Bayer AG, Lupin Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd. There is an increasing focus of the firms on improving their market position through innovations, R&D spending, joint ventures, and diversifications. In January 2025, Bayer AG intensified its association with Yuhan Corporation through signing a domestic supply contract for its Canesten products in South Korea, which will help make the Canesten products available for treating vaginal fungal infection and vaginitis. These strategic initiatives are expected to intensify competition and drive innovation across the Vaginitis Therapeutics market.
Recent Developments:
- In January 2026, Roche Diagnostics gained the CE mark approval of its Cobas® BV/CV Assay, which is a molecular diagnostic test that is intended to help diagnose bacterial vaginosis and Candida vaginitis.
- In June 2025, Organon teamed up with Evvy to offer increased availability of XACIATO® (clindamycin phosphate) vaginal gel 2%, which has been FDA-approved to treat bacterial vaginosis.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL VAGINITIS THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis AG
- Cipla Limited
- Reddy’s Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Sun Pharmaceutical Industries Limited
- Viatris Inc.
- Abbott Laboratories
- Hologic, Inc.
- Roche Diagnostics
- AstraZeneca plc
- Johnson & Johnson
- Procter & Gamble Company
- Lumavita AG
- Organon & Co.
- Alvogen
- ANI Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Others
GLOBAL VAGINITIS THERAPEUTICS MARKET, BY DISEASE- MARKET ANALYSIS, 2020 - 2033
- Anti-bacterial
- Hormone
- Anti-fungal
GLOBAL VAGINITIS THERAPEUTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Prescription
- Over-the-counter (OTC)
GLOBAL VAGINITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033
- Retail Pharmacies
- Hospital Pharmacies
- Others
GLOBAL VAGINITIS THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENTS
1. Vaginitis Therapeutics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Vaginitis Therapeutics Market Snippet by Disease
2.1.2. Vaginitis Therapeutics Market Snippet by Product
2.1.3. Vaginitis Therapeutics Market Snippet by Distribution Channel
2.1.4. Vaginitis Therapeutics Market Snippet by Country
2.1.5. Vaginitis Therapeutics Market Snippet by Region
2.2. Competitive Insights
3. Vaginitis Therapeutics Key Market Trends
3.1. Vaginitis Therapeutics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Vaginitis Therapeutics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Vaginitis Therapeutics Market Opportunities
3.4. Vaginitis Therapeutics Market Future Trends
4. Vaginitis Therapeutics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Vaginitis Therapeutics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Vaginitis Therapeutics Market Landscape
6.1. Vaginitis Therapeutics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Vaginitis Therapeutics Market – By Disease
7.1. Overview
7.1.1. Segment Share Analysis, By Disease, 2025 & 2033 (%)
7.1.2. Anti-bacterial
7.1.3. Hormone
7.1.4. Anti-fungal
8. Vaginitis Therapeutics Market – By Product
8.1. Overview
8.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
8.1.2. Prescription
8.1.3. Over-the-counter (OTC)
9. Vaginitis Therapeutics Market – By Distribution Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
9.1.2. Retail Pharmacies
9.1.3. Hospital Pharmacies
9.1.4. Others
10. Vaginitis Therapeutics Market – By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. Vaginitis Therapeutics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Vaginitis Therapeutics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Vaginitis Therapeutics Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Vaginitis Therapeutics Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Vaginitis Therapeutics Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Vaginitis Therapeutics Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Novartis AG
11.2.2. Cipla Limited
11.2.3. Dr. Reddy’s Laboratories Ltd.
11.2.4. Glenmark Pharmaceuticals Ltd.
11.2.5. Sun Pharmaceutical Industries Limited
11.2.6. Viatris Inc.
11.2.7. Abbott Laboratories
11.2.8. Hologic, Inc.
11.2.9. Roche Diagnostics
11.2.10. AstraZeneca plc
11.2.11. Johnson & Johnson
11.2.12. Procter & Gamble Company
11.2.13. Lumavita AG
11.2.14. Organon & Co.
11.2.15. Alvogen
11.2.16. ANI Pharmaceuticals, Inc.
11.2.17. Bausch Health Companies Inc.
11.2.18. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL VAGINITIS THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis AG
- Cipla Limited
- Reddy’s Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Sun Pharmaceutical Industries Limited
- Viatris Inc.
- Abbott Laboratories
- Hologic, Inc.
- Roche Diagnostics
- AstraZeneca plc
- Johnson & Johnson
- Procter & Gamble Company
- Lumavita AG
- Organon & Co.
- Alvogen
- ANI Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Others
GLOBAL VAGINITIS THERAPEUTICS MARKET, BY DISEASE- MARKET ANALYSIS, 2020 - 2033
- Anti-bacterial
- Hormone
- Anti-fungal
GLOBAL VAGINITIS THERAPEUTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Prescription
- Over-the-counter (OTC)
GLOBAL VAGINITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033
- Retail Pharmacies
- Hospital Pharmacies
- Others
GLOBAL VAGINITIS THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
